Busan, South Korea

Su Kil Seo

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Su Kil Seo from Busan, Korea

Introduction

Su Kil Seo is a prominent inventor based in Busan, South Korea. With a remarkable portfolio comprising three patents, he has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases and cancers. His innovative work illustrates not only his expertise but also his commitment to advancing medical science.

Latest Patents

Among his latest patents is a groundbreaking compound designed for the treatment of various autoimmune diseases and cancers. The compound, represented by a specific formula, may be utilized to treat or prevent conditions such as inflammatory bowel disease, multiple sclerosis, and systemic lupus erythematosus. Additionally, it encompasses various cancers, including colon cancer, melanoma, and breast cancer, promising to support the fight against these serious health challenges.

Career Highlights

Su Kil Seo has had the privilege to work with notable organizations such as Parenchyma Biotech Inc. and Chong Kun Dang Pharmaceutical Corporation. His experiences at these companies have undoubtedly shaped his innovative mindset and drive for research in medical advancements.

Collaborations

Throughout his career, Su has collaborated with talented individuals, including Eun Hye Yoon and Soung Min Lee. These collaborations have magnified his efforts and achievements in developing effective treatments, fostering a collaborative environment conducive to innovation and progress.

Conclusion

Su Kil Seo stands out as a key figure in the realm of medical patenting and invention. His dedication and ingenuity are evident in his patents aimed at addressing critical health issues. With continued research and development, he is poised to make a lasting impact on the treatment of autoimmune diseases and cancers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…